QuidelOrtho Corp QDEL

Healthcare Medical Devices

QuidelOrtho Corporation is engaged in vitro diagnostics, developing and manufacturing intelligent solutions. The Company sells its products directly to end users through a direct sales force and through a network of distributors, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, other point-of-care (POC) settings, blood banks and donor centers, as well as for individual, non-professional, over the counter (OTC) use. The Company provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Connect, Ortho Plus, Ortho Vision, QuickVue, Quidel, QuidelOrtho, QVue, Savanna, Sofia, Solana, Thyretain, Triage, Virena, Vitros among others. It provides support for its customers across more than 130 countries and territories.

NDAQ:QDEL - Post by User

QuidelOrtho Corp

<< Previous

Bullboard Posts

Post by SharpFocus619on Nov 25, 2024 3:40pm

22 Views

Post# 36329784

QDEL Can’t Match MYNZ’s Potential

QDEL’s diagnostics are broad, but MYNZ’s laser focus on CRC detection w/ ColoAlert® puts them ahead. QDEL lacks MYNZ’s partnerships like the TMO deal, setting the stage for long-term growth. Bulls sticking w/ MYNZ

<< Previous

Bullboard Posts

How one company is disrupting PoC testing